Factors Disrupting Melatonin Secretion Rhythms During Critical Illness

Matthew B Maas1,2, Bryan D Lizza3, Sabra M Abbott1,2

  • 1Department of Neurology, Northwestern University, Chicago, IL.

Critical Care Medicine
|April 23, 2020
PubMed
Abstract

Insights

Critically ill patients exhibit disrupted circadian rhythms, particularly with severe encephalopathy and vasopressor use. These disruptions in circadian rhythm and melatonin secretion are not quickly normalized by medical stabilization.

Area of Science:

  • Critical care medicine
  • Neuroscience
  • Endocrinology

Background:

  • The circadian system synchronizes physiological processes and tissue-specific functions.
  • Disruptions in circadian rhythms are common in critically ill patients, impacting recovery.
  • Understanding these disruptions is crucial for managing complex patient conditions.

Purpose of the Study:

  • To characterize acute alterations in circadian rhythms among critically ill patients.
  • To investigate the relationship between brain dysfunction, organ dysfunction, environmental stimuli, and circadian rhythms.
  • To analyze the central circadian rhythm-controlled melatonin secretion profile in intensive care unit (ICU) patients.

Main Methods:

  • A prospective study observed 112 critically ill patients (sepsis or intracerebral hemorrhage) for 24-48 hours in specialized ICUs.
  • Evaluated environmental exposures (light, feeding, activity, medications) and their impact on circadian rhythms.
  • Assessed encephalopathy (Glasgow Coma Scale), organ function (Sequential Organ Failure Assessment score), and melatonin profiles (serum and urinary 6-sulphatoxymelatonin).

Main Results:

  • Critically ill patients experienced abnormal environmental exposures, including dim light and mistimed nutrition/arousal.
  • Melatonin rhythms were generally preserved in awake patients but dampened and delayed with increased encephalopathy severity.
  • Melatonin hypersecretion was linked to vasopressor infusions, while sedatives had no effect; vasopressor changes correlated with melatonin rhythm shifts.

Conclusions:

  • Encephalopathy severity and adrenergic agonist (vasopressor) exposure significantly altered melatonin rhythms in critically ill patients.
  • Improvements in encephalopathy and medical stabilization did not rapidly restore normal circadian rhythms.
  • Urinary 6-sulphatoxymelatonin is an unreliable marker for the central circadian rhythm in critically ill populations.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
437
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.4K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
287
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
350
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.6K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
416